Why did Nvidia reach $4 trillion market cap?
How will Trump's copper tariffs impact US economy?
What caused recent recall of Ritz cracker sandwiches?
Why is Apple COO Jeff Williams stepping down?
How are Trump’s tariffs affecting global trade deals?
What led to Merck’s $10 billion Verona Pharma acquisition?
Why was FTC ‘click-to-cancel’ rule blocked by court?
KalVista price target raised to $37 from $22 at BofA
finance.yahoo.com/news/kalvista-price-target-raised-37-121624353.html
In This Article:
BofA raised the firm’s price target on KalVista (KALV) to $37 from $22 and keeps a Buy rating on the shares after the company announced the approval of Ekterly for on-demand treatment of hereditary angioedema attacks with a broad label and no restrictions on type of HAE…
This story appeared on finance.yahoo.com, 2025-07-09 12:16:24.